Skip to main content

Table 3 Assessment of subject acceptability

From: Efficacy and safety of an antiviral Iota-Carrageenan nasal spray: a randomized, double-blind, placebo-controlled exploratory study in volunteers with early symptoms of the common cold

 

ITT (n = 34)

PP (n = 32)

Subgroup (n = 11)

 

Verum (n = 16)

Placebo (n = 18)

Verum (n = 14)

Placebo (n = 18)

Verum (n = 6)

Placebo (n = 5)

Mean (SD)

6.63 (2.06)

5.39 (2.25)

7.07 (1.69)

5.39 (2.25)

7.50 (0.84)

4.20 (2.49)

p-Value

0.041

0.009

0.005

  1. Assessment of subject acceptability of Iota-Carrageenan vs. placebo nasal sprays in intention to treat (ITT), per protocol (PP) and subgroup (virus positive) analysis using a VAS scale (0- 10). P-values come from Mann-Whitney U-test. Unit: cm ± standard deviation.
Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us